Exploratory Assessment of the Clinical Value of Baseline (BL) Circulating Tumour Cells (CTC) to Predict Symptomatic Response in Pts with Functioning Midgut Neuroendocrine Tumours (NETs) Receiving Lanreotide Autogel (LAN): CALM-NET Study Results. (2019)
Attributed to:
Analysis of Cellular Heterogeneity for high resolution understanding of cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 108
Parent Publication: NEUROENDOCRINOLOGY
ISSN: 0028-3835